Literature DB >> 8309506

Incidence and risk factors for Bell's palsy in Laredo, Texas: 1974-1982.

N A Brandenburg1, J F Annegers.   

Abstract

Incidence rates of Bell's palsy in the predominantly Mexican-American population of Laredo, Texas, USA, are higher than those reported elsewhere, reaching 23.5 per 100,000 among males and 32.7 per 100,000 among females. During childbearing years (15-44) the risk of Bell's palsy was greater for women than for men (incidence density ratio 2.0; 95% confidence interval 1.3-3.1). No evidence for seasonality or epidemicity was obtained. Using prevalence estimates from community surveys in south Texas or the Hispanic Health and Nutrition Survey, standardized prevalence ratios (SPR) calculated for hypertension revealed a 10 or 20% increased risk for women and a 50 or 60% increased risk for men. SPRs calculated for diabetes among men with Bell's palsy were twice that expected, while risks of 60% or 90% were noted for women. The increased incidence of Bell's palsy observed in Laredo appears to be due to the high prevalence of diabetes in Mexican-Americans and, to a lesser extent, uncontrolled hypertension.

Entities:  

Mesh:

Year:  1993        PMID: 8309506     DOI: 10.1159/000110333

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  11 in total

1.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

Review 2.  Acupuncture for Bell's palsy.

Authors:  Ning Chen; Muke Zhou; Li He; Dong Zhou; N Li
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

Review 3.  Corticosteroids for Bell's palsy (idiopathic facial paralysis).

Authors:  Vishnu B Madhok; Ildiko Gagyor; Fergus Daly; Dhruvashree Somasundara; Michael Sullivan; Fiona Gammie; Frank Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18

4.  Physical therapy in peripheral facial paralysis: retrospective study.

Authors:  Márcia Regina Garanhani; Jefferson Rosa Cardoso; Jefferson Rosa Cardoso; Alessandra de Mello Guides Capelli; Mara Claudia Ribeiro
Journal:  Braz J Otorhinolaryngol       Date:  2007 Jan-Feb

5.  Antiviral treatment for Bell's palsy (idiopathic facial paralysis).

Authors:  Ildiko Gagyor; Vishnu B Madhok; Fergus Daly; Frank Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

6.  Weather conditions and Bell's palsy: five-year study and review of the literature.

Authors:  V Danielides; G Patrikakos; C S Nousia; A Bartzokas; H J Milionis; C Lolis; A Skevas
Journal:  BMC Neurol       Date:  2001-12-18       Impact factor: 2.474

7.  An assessment of public health surveillance of Zika virus infection and potentially associated outcomes in Latin America.

Authors:  Leonelo E Bautista; Víctor M Herrera
Journal:  BMC Public Health       Date:  2018-05-24       Impact factor: 3.295

8.  Profile of facial palsy in Arar, northern Saudi Arabia.

Authors:  Wasan Lafi Alanazi; Nagah Mohamed Abo El-Fetoh; Shahad Lafi Alanazi; Mohammed Abdullah Alkhidhr; Mohammed Abdullah Alanazi; Dounia Saleh Alonazi; Atheer Bader Alanzi; Reem Homoud Alshammari; Mashael Jaza Alshammari; Basmah Abdullah Alanazi; Samiyah Sarhan Alanazi
Journal:  Electron Physician       Date:  2017-10-25

9.  Effects of Electroacupuncture on Facial Nerve Function and HSV-1 DNA Quantity in HSV-1 Induced Facial Nerve Palsy Mice.

Authors:  Hongzhi Tang; Shuwei Feng; Jiao Chen; Jie Yang; Mingxiao Yang; Zhendong Zhong; Ying Li; Fanrong Liang
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-03       Impact factor: 2.629

10.  Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.

Authors:  David W Vaughn; Harry Seifert; Anne Hepburn; Walthere Dewe; Ping Li; Mamadou Drame; Catherine Cohet; Bruce L Innis; Louis F Fries
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.